Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial

H. Joensuu; L. Sailas; T. Alanko; K. Sunela; Riikka  Huuhtanen; M. Utriainen; R. Kokko; P. Bono; T. Wigren; S. Pyrhonen; T. Turpeenniemi-Hujanen; R. Asola; M. Leinonen; M. Hahka-Kemppinen; P. Kellokumpu-Lehtinen

doi:10.1093/annonc/mdp397

Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial

H. Joensuu, L. Sailas, T. Alanko, K. Sunela, Riikka Huuhtanen, M. Utriainen, R. Kokko, P. Bono, T. Wigren, S. Pyrhonen, T. Turpeenniemi-Hujanen, R. Asola, M. Leinonen, M. Hahka-Kemppinen, P. Kellokumpu-Lehtinen

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Annals of Oncology
Volym	21
Sidor (från-till)	968-973
Antal sidor	6
ISSN	0923-7534
DOI	https://doi.org/10.1093/annonc/mdp397
Status	Publicerad - 2010
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

312 Klinisk medicin

Åtkomst av dokument

10.1093/annonc/mdp397

Citera det här

Joensuu, H., Sailas, L., Alanko, T., Sunela, K., Huuhtanen, R., Utriainen, M., Kokko, R., Bono, P., Wigren, T., Pyrhonen, S., Turpeenniemi-Hujanen, T., Asola, R., Leinonen, M., Hahka-Kemppinen, M., & Kellokumpu-Lehtinen, P. (2010). Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial. Annals of Oncology, 21, 968-973. https://doi.org/10.1093/annonc/mdp397

@article{a0072d2f98494338abb5d2ac04285f0d,

title = "Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial",

keywords = "advanced stage, breast cancer, chemotherapy, docetaxel, gemcitabine, randomised clinical trial, PHASE-II TRIAL, 1ST-LINE CHEMOTHERAPY, SEQUENTIAL REGIMENS, SOLID TUMORS, DOXORUBICIN, PACLITAXEL, COMBINATION, WOMEN, PLUS, 312 Clinical medicine",

author = "H. Joensuu and L. Sailas and T. Alanko and K. Sunela and Riikka Huuhtanen and M. Utriainen and R. Kokko and P. Bono and T. Wigren and S. Pyrhonen and T. Turpeenniemi-Hujanen and R. Asola and M. Leinonen and M. Hahka-Kemppinen and P. Kellokumpu-Lehtinen",

year = "2010",

doi = "10.1093/annonc/mdp397",

language = "English",

volume = "21",

pages = "968--973",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Joensuu, H, Sailas, L, Alanko, T, Sunela, K, Huuhtanen, R, Utriainen, M, Kokko, R, Bono, P, Wigren, T, Pyrhonen, S, Turpeenniemi-Hujanen, T, Asola, R, Leinonen, M, Hahka-Kemppinen, M & Kellokumpu-Lehtinen, P 2010, 'Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial', Annals of Oncology, vol. 21, s. 968-973. https://doi.org/10.1093/annonc/mdp397

TY - JOUR

T1 - Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial

AU - Joensuu, H.

AU - Sailas, L.

AU - Alanko, T.

AU - Sunela, K.

AU - Huuhtanen, Riikka

AU - Utriainen, M.

AU - Kokko, R.

AU - Bono, P.

AU - Wigren, T.

AU - Pyrhonen, S.

AU - Turpeenniemi-Hujanen, T.

AU - Asola, R.

AU - Leinonen, M.

AU - Hahka-Kemppinen, M.

AU - Kellokumpu-Lehtinen, P.

PY - 2010

Y1 - 2010

KW - advanced stage

KW - breast cancer

KW - chemotherapy

KW - docetaxel

KW - gemcitabine

KW - randomised clinical trial

KW - PHASE-II TRIAL

KW - 1ST-LINE CHEMOTHERAPY

KW - SEQUENTIAL REGIMENS

KW - SOLID TUMORS

KW - DOXORUBICIN

KW - PACLITAXEL

KW - COMBINATION

KW - WOMEN

KW - PLUS

KW - 312 Clinical medicine

U2 - 10.1093/annonc/mdp397

DO - 10.1093/annonc/mdp397

M3 - Article

SN - 0923-7534

VL - 21

SP - 968

EP - 973

JO - Annals of Oncology

JF - Annals of Oncology

ER -